biotechnology

biotechnology

The steady trader uses stochastics to chart Facebook - IG Live 22.04.2014

20h ago
SOURCE  

Description

Serge Berger says he prefers to wait for Facebook's earnings to come out before trading it. Going into them he says there is a very defined risk at $55.90 -- if it goes below that he sees that it will go lower towards the 200 day moving average, on the upside, the stock could get back to $70. He also uses technical analysis to chart the Russell 2000 and Nasdaq biotechnology index. Technical analysis interview with Serge Berger from Blue Oak Advisors and Sara Walker on IG Live. http://www.ig.com/uk/live-video These thoughts are Serge Berger's own and do not constitute investment advice. IG accepts no responsibility for any use that may be made of them.